First Horizon Advisors’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,600	Closed	-$5.12K	–	2389
2023 Q2	$5.12K	Buy	+5,600	New	+$5.12K	﹤0.01%	1782
2021 Q4	–	Sell	-63	Closed	–	–	2247
2021 Q3	$0	Buy	+63	New	–	﹤0.01%	2268